Bamlanivimab as monotherapy in two immunocompromised patients with COVID-19.

Lancet Microbe

Laboratoire de Virologie, Centre National de Référence France-Sud des Virus des Infections Respiratoires, Institut des Agents Infectieux, Hospices Civils de Lyon, Groupement Hospitalier Nord, 69004 Lyon, France.

Published: September 2021

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318407PMC
http://dx.doi.org/10.1016/S2666-5247(21)00189-0DOI Listing

Publication Analysis

Top Keywords

bamlanivimab monotherapy
4
monotherapy immunocompromised
4
immunocompromised patients
4
patients covid-19
4
bamlanivimab
1
immunocompromised
1
patients
1
covid-19
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!